Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleOMERACT 9: International Consensus Conference on Outcome Measures in Rheumatology, Kananaskis Village, Alberta, Canada, May 27–31, 2008

Synovial Tissue Sublining CD68 Expression Is a Biomarker of Therapeutic Response in Rheumatoid Arthritis Clinical Trials: Consistency Across Centers

BARRY BRESNIHAN, ELIZA PONTIFEX, ROGIER M. THURLINGS, MARJOLEIN VINKENOOG, HANI EL-GABALAWY, URSULA FEARON, OLIVER FITZGERALD, DANIELLE M. GERLAG, TERENCE ROONEY, MARLEEN G. van de SANDE, DOUGLAS VEALE, KOEN VOS and PAUL-PETER TAK
The Journal of Rheumatology August 2009, 36 (8) 1800-1802; DOI: https://doi.org/10.3899/jrheum.090348
BARRY BRESNIHAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: barry.bresnihan@gmail.com
ELIZA PONTIFEX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROGIER M. THURLINGS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARJOLEIN VINKENOOG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HANI EL-GABALAWY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
URSULA FEARON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OLIVER FITZGERALD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DANIELLE M. GERLAG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TERENCE ROONEY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARLEEN G. van de SANDE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOUGLAS VEALE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOEN VOS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAUL-PETER TAK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Gerlag DM,
    2. Haringman JJ,
    3. Smeets TJ,
    4. et al.
    Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis. Arthritis Rheum 2004;50:3783–91.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Haringman JJ,
    2. Gerlag DM,
    3. Zwinderman AH
    . Synovial tissue macrophages: Highly sensitive biomarkers for response to treatment in rheumatoid arthritis patients. Ann Rheum Dis 2005;64:834–8.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Bresnihan B,
    2. Gerlag DM,
    3. Rooney T,
    4. et al.
    Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: Standardization and consistency across centers. J Rheumatol 2007;34:620–2.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Gerlag D,
    2. Tak PP
    . Novel approaches for the treatment of rheumatoid arthritis: Lessons from the evaluation of synovial biomarkers in clinical trials. Best Pract Res Clin Rheumatol 2008;22:311–23.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Wijbrandts CA,
    2. Vergunst CE,
    3. Haringman JJ,
    4. Gerlag DM,
    5. Smeets TJ,
    6. Tak PP
    . Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarker. Arthritis Rheum 2007;56:3869–71.
    OpenUrlCrossRefPubMed
  6. 6.
    1. Vergunst CE,
    2. Gerlag DM,
    3. Dinant H,
    4. et al.
    Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation. Rheumatology 2007;46:1773–8.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Vergunst CE,
    2. Gerlag DM,
    3. Lopatinskaya L,
    4. et al.
    Modulation of CCR2 in rheumatoid arthritis: A double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum 2008;58:1931–9.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Vos K,
    2. Thurlings RM,
    3. Wijbrandts CA,
    4. van Schaardenburg D,
    5. Gerlag DM,
    6. Tak PP
    . Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis. Arthritis Rheum 2007;56:772–8.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Thurlings RM,
    2. Vos K,
    3. Wijbrandts CA,
    4. Zwinderman A,
    5. Gerlag DM,
    6. Tak PP
    . Synovial tissue response to rituximab: Mechanism of action and identification of biomarkers of response. Ann Rheum Dis 2008;67:917–25.
    OpenUrlAbstract/FREE Full Text
  10. 10.
    1. Arnett FC,
    2. Edworthy SM,
    3. Bloch DA,
    4. et al.
    The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;312:315–24.
    OpenUrl
  11. 11.↵
    1. Prevoo ML,
    2. van’t Hof MA,
    3. Kuper HH,
    4. Van Leeuwen MA,
    5. Van De Putte LB,
    6. Van Riel PL
    . Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Rooney T,
    2. Bresnihan B,
    3. Andersson U,
    4. et al.
    Microscopic measurement of inflammation in synovial tissue: inter-observer agreement for manual quantitative, semiquantitative and computerised digital image analysis. Ann Rheum Dis 2007;66:1656–60.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Haringman JJ,
    2. Vinkenoog M,
    3. Gerlag DM,
    4. Smeets TJ,
    5. Zwinderman AH,
    6. Tak PP
    . Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomized controlled trials in rheumatoid arthritis. Arthritis Res Ther 2005;7:R862–7.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Gerlag DM,
    2. Tak PP
    . Synovial biopsy. Best Pract Res Clin Rheumatol 2005;19:387–400.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Gerlag DM,
    2. Boyle DL,
    3. Rosengren S,
    4. Nash T,
    5. Tak PP,
    6. Firestein GS
    . Real-time quantitative PCR to detect changes in synovial gene expression in rheumatoid arthritis after corticosteroid treatment. Ann Rheum Dis 2007;66:545–7.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. van der Pouw Kraan TC,
    2. Wijbrandts CA,
    3. van Baarsen LG,
    4. et al.
    Responsiveness to anti-TNF-α therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients. Ann Rheum Dis 2008;67:563–6.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 36, Issue 8
1 Aug 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Synovial Tissue Sublining CD68 Expression Is a Biomarker of Therapeutic Response in Rheumatoid Arthritis Clinical Trials: Consistency Across Centers
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Synovial Tissue Sublining CD68 Expression Is a Biomarker of Therapeutic Response in Rheumatoid Arthritis Clinical Trials: Consistency Across Centers
BARRY BRESNIHAN, ELIZA PONTIFEX, ROGIER M. THURLINGS, MARJOLEIN VINKENOOG, HANI EL-GABALAWY, URSULA FEARON, OLIVER FITZGERALD, DANIELLE M. GERLAG, TERENCE ROONEY, MARLEEN G. van de SANDE, DOUGLAS VEALE, KOEN VOS, PAUL-PETER TAK
The Journal of Rheumatology Aug 2009, 36 (8) 1800-1802; DOI: 10.3899/jrheum.090348

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Synovial Tissue Sublining CD68 Expression Is a Biomarker of Therapeutic Response in Rheumatoid Arthritis Clinical Trials: Consistency Across Centers
BARRY BRESNIHAN, ELIZA PONTIFEX, ROGIER M. THURLINGS, MARJOLEIN VINKENOOG, HANI EL-GABALAWY, URSULA FEARON, OLIVER FITZGERALD, DANIELLE M. GERLAG, TERENCE ROONEY, MARLEEN G. van de SANDE, DOUGLAS VEALE, KOEN VOS, PAUL-PETER TAK
The Journal of Rheumatology Aug 2009, 36 (8) 1800-1802; DOI: 10.3899/jrheum.090348
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fibromyalgia Syndrome Module at OMERACT 9: Domain Construct
  • Content and Criterion Validity of the Preliminary Core Dataset for Clinical Trials in Fibromyalgia Syndrome
  • Developing a Standardized Definition for Disease “Flare” in Rheumatoid Arthritis (OMERACT 9 Special Interest Group)
Show more OMERACT 9: International Consensus Conference on Outcome Measures in Rheumatology, Kananaskis Village, Alberta, Canada, May 27–31, 2008

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire